» Articles » PMID: 24710339

Increasing the Content of High-Content Screening: An Overview

Overview
Journal J Biomol Screen
Publisher Sage Publications
Date 2014 Apr 9
PMID 24710339
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Target-based high-throughput screening (HTS) has recently been critiqued for its relatively poor yield compared to phenotypic screening approaches. One type of phenotypic screening, image-based high-content screening (HCS), has been seen as particularly promising. In this article, we assess whether HCS is as high content as it can be. We analyze HCS publications and find that although the number of HCS experiments published each year continues to grow steadily, the information content lags behind. We find that a majority of high-content screens published so far (60-80%) made use of only one or two image-based features measured from each sample and disregarded the distribution of those features among each cell population. We discuss several potential explanations, focusing on the hypothesis that data analysis traditions are to blame. This includes practical problems related to managing large and multidimensional HCS data sets as well as the adoption of assay quality statistics from HTS to HCS. Both may have led to the simplification or systematic rejection of assays carrying complex and valuable phenotypic information. We predict that advanced data analysis methods that enable full multiparametric data to be harvested for entire cell populations will enable HCS to finally reach its potential.

Citing Articles

Data stewardship and curation practices in AI-based genomics and automated microscopy image analysis for high-throughput screening studies: promoting robust and ethical AI applications.

Taddese A, Addis A, Tam B Hum Genomics. 2025; 19(1):16.

PMID: 39988670 PMC: 11849233. DOI: 10.1186/s40246-025-00716-x.


A versatile information retrieval framework for evaluating profile strength and similarity.

Kalinin A, Arevalo J, Serrano E, Vulliard L, Tsang H, Bornholdt M bioRxiv. 2024; .

PMID: 38617315 PMC: 11014546. DOI: 10.1101/2024.04.01.587631.


High-Throughput Methods for the Discovery of Small Molecule Modulators of Pancreatic Beta-Cell Function and Regeneration.

McCarty S, Clasby M, Sexton J Assay Drug Dev Technol. 2024; 22(3):148-159.

PMID: 38526231 PMC: 11236284. DOI: 10.1089/adt.2023.119.


Transfer learning for versatile and training free high content screening analyses.

Corbe M, Boncompain G, Perez F, Del Nery E, Genovesio A Sci Rep. 2023; 13(1):22599.

PMID: 38114550 PMC: 10730630. DOI: 10.1038/s41598-023-49554-8.


Morphology-based deep learning approach for predicting adipogenic and osteogenic differentiation of human mesenchymal stem cells (hMSCs).

Mai M, Luo S, Fasciano S, Oluwole T, Ortiz J, Pang Y Front Cell Dev Biol. 2023; 11:1329840.

PMID: 38099293 PMC: 10720363. DOI: 10.3389/fcell.2023.1329840.


References
1.
Kozak K, Csucs G . Kernelized Z' factor in multiparametric screening technology. RNA Biol. 2010; 7(5):615-20. DOI: 10.4161/rna.7.5.13239. View

2.
Kim M, Lim C, Lee J, Im K, Yoon K, Song J . Visible-to-near IR quantum dot-based hypermulticolor high-content screening of herbal medicines for the efficacy monitoring of hair growth promotion and hair loss inhibition. J Biomol Screen. 2012; 18(4):462-73. DOI: 10.1177/1087057112464574. View

3.
Sexton J, He Q, Forsberg L, Brenman J . High content screening for non-classical peroxisome proliferators. Int J High Throughput Screen. 2010; 2010(1):127-140. PMC: 2995584. DOI: 10.2147/IJHTS.S10547. View

4.
Rao T, Rosales N, Spriggs D . Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents. Mol Cancer Ther. 2011; 10(10):1939-48. PMC: 3191303. DOI: 10.1158/1535-7163.MCT-11-0228. View

5.
Giuliano K, Chen Y, Taylor D . High-content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of P53 activation in the cellular response to anticancer drugs. J Biomol Screen. 2004; 9(7):557-68. DOI: 10.1177/1087057104265387. View